[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615100":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":25,"locations":31,"responsibleParty":331,"collaborators":333,"id":336,"slug":24,"hasResults":337,"nctId":338,"briefTitle":339,"officialTitle":340,"acronym":24,"eligibilityCriteria":341,"healthyVolunteers":337,"sex":342,"minAge":343,"maxAge":344,"enrollmentInfo":345,"targetDuration":24,"studyType":348,"phases":349,"briefSummary":351,"conditions":352,"keywords":356,"overallStatus":34,"whyStopped":24,"lastUpdateSubmitDate":359,"lastUpdatePostDateStruct":360,"startDateStruct":363,"completionDateStruct":365,"leadSponsor":367,"locationsCount":368},{"fullName":5,"class":6},"Kiniksa Pharmaceuticals International, plc","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Posology KPL-387","EXPERIMENTAL","In Posology Study, KPL-387 will be administered by subcutaneous (SC) injection through Week 16.",[13],"Drug: KPL-387",{"label":15,"type":10,"description":16,"interventionNames":17},"Long-Term Extension","Participants from Posology Study who continue into the Long-Term Extension will receive KPL-387 for up to 24 months or until KPL-387 is approved for commercial use in that region to treat pericarditis, whichever occurs first.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","KPL-387","administered by subcutaneous injection",[15,9],null,[26],{"name":27,"role":28,"phone":29,"phoneExt":24,"email":30},"Clinical Project Manager","CONTACT","781-431-9100","clinicaltrials@kiniksa.com",[32,45,55,64,74,84,94,103,109,119,129,138,148,157,166,177,187,196,205,215,224,234,243,253,263,269,279,285,294,300,309,319,325],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":24},"Investigational Site 031","RECRUITING","Phoenix","Arizona","85054","United States",{"type":40,"coordinates":41},"Point",[42,43],-112.07404,33.44838,{"lat":43,"lon":42},{"facility":46,"status":34,"city":47,"state":48,"zip":49,"country":38,"cosmosGeoPoint":50,"geoPoint":54,"contacts":24},"Investigational Site 014","Los Angeles","California","90048",{"type":40,"coordinates":51},[52,53],-118.24368,34.05223,{"lat":53,"lon":52},{"facility":56,"status":34,"city":57,"state":48,"zip":58,"country":38,"cosmosGeoPoint":59,"geoPoint":63,"contacts":24},"Investigational Site 002","Santa Monica","90404",{"type":40,"coordinates":60},[61,62],-118.49138,34.01949,{"lat":62,"lon":61},{"facility":65,"status":34,"city":66,"state":67,"zip":68,"country":38,"cosmosGeoPoint":69,"geoPoint":73,"contacts":24},"Investigational Site 013","Chicago","Illinois","60611",{"type":40,"coordinates":70},[71,72],-87.65005,41.85003,{"lat":72,"lon":71},{"facility":75,"status":34,"city":76,"state":77,"zip":78,"country":38,"cosmosGeoPoint":79,"geoPoint":83,"contacts":24},"Investigational Site 025","Baltimore","Maryland","21287",{"type":40,"coordinates":80},[81,82],-76.61219,39.29038,{"lat":82,"lon":81},{"facility":85,"status":34,"city":86,"state":87,"zip":88,"country":38,"cosmosGeoPoint":89,"geoPoint":93,"contacts":24},"Investigational Site 028","Rochester","Minnesota","55905",{"type":40,"coordinates":90},[91,92],-92.4699,44.02163,{"lat":92,"lon":91},{"facility":95,"status":34,"city":96,"state":96,"zip":97,"country":38,"cosmosGeoPoint":98,"geoPoint":102,"contacts":24},"Investigational Site 011","New York","10016",{"type":40,"coordinates":99},[100,101],-74.00597,40.71427,{"lat":101,"lon":100},{"facility":104,"status":34,"city":96,"state":96,"zip":105,"country":38,"cosmosGeoPoint":106,"geoPoint":108,"contacts":24},"Investigational Site 003","10032",{"type":40,"coordinates":107},[100,101],{"lat":101,"lon":100},{"facility":110,"status":34,"city":111,"state":112,"zip":113,"country":38,"cosmosGeoPoint":114,"geoPoint":118,"contacts":24},"Investigational Site 009","Cincinnati","Ohio","45219",{"type":40,"coordinates":115},[116,117],-84.51439,39.12711,{"lat":117,"lon":116},{"facility":120,"status":34,"city":121,"state":122,"zip":123,"country":38,"cosmosGeoPoint":124,"geoPoint":128,"contacts":24},"Investigational Site 005","Austin","Texas","78705",{"type":40,"coordinates":125},[126,127],-97.74306,30.26715,{"lat":127,"lon":126},{"facility":130,"status":34,"city":131,"state":122,"zip":132,"country":38,"cosmosGeoPoint":133,"geoPoint":137,"contacts":24},"Investigational Site 006","Houston","77030",{"type":40,"coordinates":134},[135,136],-95.36327,29.76328,{"lat":136,"lon":135},{"facility":139,"status":34,"city":140,"state":141,"zip":142,"country":38,"cosmosGeoPoint":143,"geoPoint":147,"contacts":24},"Investigational Site 004","Charlottesville","Virginia","22903",{"type":40,"coordinates":144},[145,146],-78.47668,38.02931,{"lat":146,"lon":145},{"facility":149,"status":34,"city":150,"state":141,"zip":151,"country":38,"cosmosGeoPoint":152,"geoPoint":156,"contacts":24},"Investigational Site 001","Norfolk","23507",{"type":40,"coordinates":153},[154,155],-76.28522,36.84681,{"lat":155,"lon":154},{"facility":158,"status":34,"city":159,"state":141,"zip":160,"country":38,"cosmosGeoPoint":161,"geoPoint":165,"contacts":24},"Investigational Site 008","Richmond","23284",{"type":40,"coordinates":162},[163,164],-77.46026,37.55376,{"lat":164,"lon":163},{"facility":167,"status":34,"city":168,"state":169,"zip":170,"country":171,"cosmosGeoPoint":172,"geoPoint":176,"contacts":24},"Investigational Site 010","Ottawa","Ontario","K1N 6N5","Canada",{"type":40,"coordinates":173},[174,175],-75.69812,45.41117,{"lat":175,"lon":174},{"facility":178,"status":34,"city":179,"state":24,"zip":180,"country":181,"cosmosGeoPoint":182,"geoPoint":186,"contacts":24},"Investigational Site 027","Paris","75013","France",{"type":40,"coordinates":183},[184,185],2.3488,48.85341,{"lat":185,"lon":184},{"facility":188,"status":34,"city":189,"state":24,"zip":190,"country":181,"cosmosGeoPoint":191,"geoPoint":195,"contacts":24},"Investigational Site 026","Poitiers","86000",{"type":40,"coordinates":192},[193,194],0.34348,46.58261,{"lat":194,"lon":193},{"facility":197,"status":34,"city":198,"state":24,"zip":199,"country":181,"cosmosGeoPoint":200,"geoPoint":204,"contacts":24},"Investigational Site 032","Toulouse","31400",{"type":40,"coordinates":201},[202,203],1.44367,43.60426,{"lat":203,"lon":202},{"facility":206,"status":34,"city":207,"state":24,"zip":208,"country":209,"cosmosGeoPoint":210,"geoPoint":214,"contacts":24},"Investigational Site 023","Nea Ionia","142 33","Greece",{"type":40,"coordinates":211},[212,213],23.75733,38.0357,{"lat":213,"lon":212},{"facility":216,"status":34,"city":217,"state":24,"zip":218,"country":209,"cosmosGeoPoint":219,"geoPoint":223,"contacts":24},"Investigational Site 024","Voula","166 73",{"type":40,"coordinates":220},[221,222],23.77651,37.84221,{"lat":222,"lon":221},{"facility":225,"status":34,"city":226,"state":24,"zip":227,"country":228,"cosmosGeoPoint":229,"geoPoint":233,"contacts":24},"Investigational Site 021","Milan","20157","Italy",{"type":40,"coordinates":230},[231,232],9.18951,45.46427,{"lat":232,"lon":231},{"facility":235,"status":34,"city":236,"state":24,"zip":237,"country":228,"cosmosGeoPoint":238,"geoPoint":242,"contacts":24},"Investigational Site 033","Udine","33100",{"type":40,"coordinates":239},[240,241],13.23715,46.0693,{"lat":241,"lon":240},{"facility":244,"status":34,"city":245,"state":24,"zip":246,"country":247,"cosmosGeoPoint":248,"geoPoint":252,"contacts":24},"Investigational Site 020","Warsaw","02-507","Poland",{"type":40,"coordinates":249},[250,251],21.01178,52.22977,{"lat":251,"lon":250},{"facility":254,"status":34,"city":255,"state":24,"zip":256,"country":257,"cosmosGeoPoint":258,"geoPoint":262,"contacts":24},"Investigational Site 030","Belgrade","1100","Serbia",{"type":40,"coordinates":259},[260,261],20.46513,44.80401,{"lat":261,"lon":260},{"facility":264,"status":34,"city":255,"state":24,"zip":265,"country":257,"cosmosGeoPoint":266,"geoPoint":268,"contacts":24},"Investigational Site 029","11040",{"type":40,"coordinates":267},[260,261],{"lat":261,"lon":260},{"facility":270,"status":34,"city":271,"state":24,"zip":272,"country":273,"cosmosGeoPoint":274,"geoPoint":278,"contacts":24},"Investigational Site 019","Barcelona","08017","Spain",{"type":40,"coordinates":275},[276,277],2.15899,41.38879,{"lat":277,"lon":276},{"facility":280,"status":34,"city":271,"state":24,"zip":281,"country":273,"cosmosGeoPoint":282,"geoPoint":284,"contacts":24},"Investigational Site 015","08035",{"type":40,"coordinates":283},[276,277],{"lat":277,"lon":276},{"facility":286,"status":34,"city":287,"state":24,"zip":288,"country":273,"cosmosGeoPoint":289,"geoPoint":293,"contacts":24},"Investigational Site 017","Madrid","28034",{"type":40,"coordinates":290},[291,292],-3.70256,40.4165,{"lat":292,"lon":291},{"facility":295,"status":34,"city":287,"state":24,"zip":296,"country":273,"cosmosGeoPoint":297,"geoPoint":299,"contacts":24},"Investigational Site 016","28850",{"type":40,"coordinates":298},[291,292],{"lat":292,"lon":291},{"facility":301,"status":34,"city":302,"state":24,"zip":303,"country":273,"cosmosGeoPoint":304,"geoPoint":308,"contacts":24},"Investigational Site 018","Valencia","46015",{"type":40,"coordinates":305},[306,307],-0.37966,39.47391,{"lat":307,"lon":306},{"facility":310,"status":34,"city":311,"state":24,"zip":312,"country":313,"cosmosGeoPoint":314,"geoPoint":318,"contacts":24},"Investigational Site 012","London","EC1A 7BE","United Kingdom",{"type":40,"coordinates":315},[316,317],-0.12574,51.50853,{"lat":317,"lon":316},{"facility":320,"status":34,"city":311,"state":24,"zip":321,"country":313,"cosmosGeoPoint":322,"geoPoint":324,"contacts":24},"Investigational Site 022","NW3 2QG",{"type":40,"coordinates":323},[316,317],{"lat":317,"lon":316},{"facility":326,"status":34,"city":311,"state":24,"zip":327,"country":313,"cosmosGeoPoint":328,"geoPoint":330,"contacts":24},"Investigational Site 007","SE1 7EH",{"type":40,"coordinates":329},[316,317],{"lat":317,"lon":316},{"type":332,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[334],{"name":335,"class":6},"Kiniksa Pharmaceuticals, GmbH","100615100",false,"NCT07288216","Transition to KPL-387 Monotherapy Dosing & Administration Study","A Phase 2 Posology Study With Long-Term Extension in Participants With Well-Controlled Recurrent Pericarditis to Evaluate the Efficacy and Safety of Transition Regimens to KPL-387 Monotherapy From Standard Therapies","Key Inclusion Criteria:\n\n* Has well-controlled recurrent pericarditis (i.e., including having CRP \\\u003C 0.5 mg\u002FdL within 14 days of Baseline and a pericarditis pain NRS score ≤ 3 at Baseline)\n* Has a documented history of CRP elevation (\\> 1 mg\u002FdL) associated with at least one prior acute pericarditis episode, whether the incident event or any pericarditis recurrence\n* Has received treatment for RP for at least 3 months prior to Baseline with standard therapy(ies) and is currently on a stable dosing regimen including NSAIDs and\u002For colchicine, and\u002For glucocorticoids or an IL-1 pathway inhibitor (anakinra or rilonacept).\n\nKey Exclusion Criteria:\n\n* Has a diagnosis of pericarditis that is secondary to specific prohibited etiologies\n* Has had a pericarditis recurrence in the last 3 months prior to Baseline\n* Has received an investigational drug during the 4 weeks before study drug administration or is planning to receive an investigational drug at any time during the study.\n* Has a history of active or untreated, latent tuberculosis (TB) prior to screening.\n* Has a history of immunodeficiency.\n* Has a history of immunosuppression, including positive human immunodeficiency virus (HIV) test results.\n* Has chest x-ray at Screening or within 12 weeks before first study drug administration, with evidence of malignancy, abnormality consistent with prior or active TB infection or active infection.\n* Has a history of malignancy of any organ system within the past 5 years before Screening (other than a successfully treated non-metastatic cutaneous squamous cell carcinoma or basal cell carcinoma and\u002For localized carcinoma in situ of the cervix).\n* Has a known or suspected current active infection or a history of chronic or recurrent infectious disease (\\> 3 episodes in prior 12 months), including but not limited to, genitourinary infection, chest infection, sinusitis, or skin\u002Fsoft tissue infection.\n* Has had a serious infection, has been admitted to the hospital for an infection, or has been treated for a documented infection requiring antibiotics for a documented infection within 2 weeks prior to first study drug administration.\n* Has had an organ transplant (except corneal transplant performed more than 3 months prior to first study drug administration).\n* In the Investigator's opinion, has any other medical condition that could adversely affect the subject's participation or interfere with study evaluations.","ALL","18 Years","80 Years",{"count":346,"type":347},80,"ESTIMATED","INTERVENTIONAL",[350],"PHASE2","The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapies to KPL-387 monotherapy in participants with well-controlled recurrent pericarditis on standard therapies.",[353,354,355],"Recurrent Pericarditis","Heart Diseases","Pericarditis",[357,358,21,353],"Recurrence","Recurrent","2026-06-18",{"date":361,"type":362},"2026-06-22","ACTUAL",{"date":364,"type":362},"2026-03-25",{"date":366,"type":347},"2029-12-31",{"name":5,"class":6},33]